BURIED in the news a few weeksago was an announcement by a small Californian firm called Amyris.

之前的几个星期，一直沉浸在加州一家叫做Amyris的小公司所发布的新闻里。

youdao

Procter &Gamble, a consumer-products giant, recently agreed to use some biochemicals made by Amyris in its products.

而宝洁，日用消费品巨头，最近则同意在产品中使用部分阿米利斯公司生产的生化试剂。

youdao

Amyris started off using large-scale genetic engineering, also known as synthetic biology, to create bugs that make a malaria drug.

阿米瑞斯生物技术公司开始运行时大规模使用也被称作合成生物技术的基因工程来培养能够制作治疗疟疾的药物的细菌。

youdao

John Melo is the CEO of Amyris and has a stellar 20-year background in the energy industry.

FORBES: Cunning Capitalists Go Blazing Into Biofuels

Sometimes one company missing its IPO forecast, as Amyris has done, can create buying opportunities in the sector.

FORBES: The Big Green Opportunity: Transforming Clean Tech Into "Main Tech"

Gevo and Amyris have both figured that out and left the biofuel business.

FORBES: The U.S. Navy: Defending Our Freedom And ... Building Our Refineries